Litcius/Paper detail

Natural products as home‐based prophylactic and symptom management agents in the setting of <scp>COVID</scp>‐19

Thota Sai Manohar, Venkatesh Balan, Venketesh Sivaramakrishnan

2020Phytotherapy Research89 citationsDOIOpen Access PDF

Abstract

Coronavirus disease (COVID-19) caused by the novel coronavirus (SARS-CoV-2) has rapidly spread across the globe affecting 213 countries or territories with greater than six million confirmed cases and about 0.37 million deaths, with World Health Organization categorizing it as a pandemic. Infected patients present with fever, cough, shortness of breath, and critical cases show acute respiratory infection and multiple organ failure. Likelihood of these severe indications is further enhanced by age as well as underlying comorbidities such as diabetes, cardiovascular, or thoracic problems, as well as due to an immunocompromised state. Currently, curative drugs or vaccines are lacking, and the standard of care is limited to symptom management. Natural products like ginger, turmeric, garlic, onion, cinnamon, lemon, neem, basil, and black pepper have been scientifically proven to have therapeutic benefits against acute respiratory tract infections including pulmonary fibrosis, diffuse alveolar damage, pneumonia, and acute respiratory distress syndrome, as well as associated septic shock, lung and kidney injury, all of which are symptoms associated with COVID-19 infection. This review highlights the potential of these natural products to serve as home-based, inexpensive, easily accessible, prophylactic agents against COVID-19.

Topics & Concepts

Coronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)PandemicMedicineBetacoronavirusVirologyInternal medicineOutbreakInfectious disease (medical specialty)DiseasePiperaceae Chemical and Biological StudiesHerbal Medicine Research StudiesMedicinal Plants and Bioactive Compounds
Natural products as home‐based prophylactic and symptom management agents in the setting of <scp>COVID</scp>‐19 | Litcius